Comparison of three different docetaxel and cisplatin plus fluorouracil (DCF) as first-line therapy for advanced gastric cancer: A retrospective analysis of the two institution

dc.contributor.authorInal, A.
dc.contributor.authorKoca, D.
dc.contributor.authorKaplan, M. A.
dc.contributor.authorKucukoner, M.
dc.contributor.authorUrakci, Z.
dc.contributor.authorDogan, E.
dc.contributor.authorIsikdogan, A.
dc.date.accessioned2024-04-24T17:47:42Z
dc.date.available2024-04-24T17:47:42Z
dc.date.issued2013
dc.departmentDicle Üniversitesien_US
dc.descriptionEuropean Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO -- SEP 27-OCT 01, 2013 -- Amsterdam, NETHERLANDSen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipEuropean Conf Clin Oncol,European Soc Therapeut Radiol & Oncol,European Soc Med Oncol,European Soc Surg Oncol,European Assoc Canc Res,European Oncol Nursing Soc,European Soc Paediat Oncolen_US
dc.identifier.endpageS622en_US
dc.identifier.issn0959-8049
dc.identifier.issn1879-0852
dc.identifier.startpageS622en_US
dc.identifier.urihttps://hdl.handle.net/11468/22697
dc.identifier.volume49en_US
dc.identifier.wosWOS:000326843604043
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherElsevier Sci Ltden_US
dc.relation.ispartofEuropean Journal of Cancer
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keyword]en_US
dc.titleComparison of three different docetaxel and cisplatin plus fluorouracil (DCF) as first-line therapy for advanced gastric cancer: A retrospective analysis of the two institutionen_US
dc.titleComparison of three different docetaxel and cisplatin plus fluorouracil (DCF) as first-line therapy for advanced gastric cancer: A retrospective analysis of the two institution
dc.typeConference Objecten_US

Dosyalar